|
Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
| 262.25 EUR | 0.00% |
|
0.00% | - |
| 06-25 | US prices for new drugs fell in 2025 as fewer costly gene therapies were launched | RE |
| 06-22 | UBS Trims UCB's PT, Affirms Buy Rating | MT |
Main competitors
| Change | 5-day change | 1-month change | 3-month change | YTD change | 1-year change | 3-year change | 5-year change | 10-year change | Capi.($) | ||
|---|---|---|---|---|---|---|---|---|---|---|---|
 | -2.38% | +0.93% | +3.84% | -16.75% | -19.19% | +18.81% | -13.19% | +11.68% | +78.61% | 64.28B | |
| -3.94% | +39.10% | +39.10% | +39.10% | +39.10% | +39.10% | +39.10% | +39.10% | - | 43.45B | |
| -0.56% | +1.65% | +18.77% | -19.87% | -33.54% | -51.04% | -58.77% | -60.42% | +5.89% | 38.02B | |
| -3.82% | +9.80% | +12.64% | +15.43% | +23.03% | +72.40% | -23.99% | -37.47% | -10.46% | 31.98B | |
| -0.14% | +14.33% | +51.41% | +44.60% | +136.49% | +152.77% | -42.60% | -70.32% | - | 27.66B | |
| -0.99% | +9.17% | +19.23% | +26.17% | +15.39% | +67.36% | +83.08% | +35.47% | +42.50% | 22.91B | |
| -0.56% | +5.64% | -4.50% | -6.90% | +4.39% | +2.91% | +174.96% | -13.38% | - | 17.74B | |
| -0.13% | +3.87% | +4.48% | +19.81% | +38.82% | +62.33% | +122.76% | +196.63% | +346.38% | 16.45B | |
| +0.19% | +8.36% | +13.79% | +7.22% | -2.77% | +72.23% | +332.38% | +22.00% | - | 14.1B | |
| -3.22% | +3.00% | -2.17% | -5.25% | -19.69% | -5.12% | +762.60% | +428.29% | +6,722.05% | 12.95B | |
| +0.81% | +0.97% | +6.11% | +52.22% | +33.77% | +134.04% | +239.98% | +262.16% | +3,140.19% | 12.41B | |
| +9.15% | +9.13% | +24.55% | +50.35% | +50.59% | +170.09% | +216.24% | +445.99% | - | 11.15B | |
| -1.65% | +1.60% | +4.32% | +4.77% | -3.41% | +4.43% | -33.77% | -31.20% | -26.21% | 11.15B | |
| +6.73% | +28.79% | +19.48% | +7.64% | +29.25% | +44.21% | +350.26% | +280.60% | - | 6.56B | |
| +0.30% | -0.73% | -3.45% | +2.66% | -16.26% | -13.26% | -22.26% | -60.51% | -54.46% | 6.27B | |
| +2.37% | +20.45% | +50.87% | +136.66% | +222.76% | +178.28% | +400.39% | -23.17% | - | 6.13B | |
| -2.26% | +4.97% | -8.70% | -29.57% | -30.15% | -25.59% | +119.64% | +86.84% | +114.07% | 5.51B | |
| -1.14% | -5.83% | -22.19% | -32.46% | -39.99% | -56.07% | -59.53% | -78.72% | - | 5.07B | |
| -1.41% | -0.39% | +8.57% | -8.04% | -16.62% | +5.84% | +47.47% | -49.09% | - | 5.04B | |
| Average | -0.29% | +6.03% | +12.43% | +15.15% | +21.68% | +45.98% | +138.67% | +72.87% | +1,035.85% | 18.89B | |
| Weighted average by Cap. | -0.98% | +5.63% | +16.12% | +11.78% | +17.90% | +43.45% | +79.37% | +43.76% | +620.14% |
- Stock Market
- Stocks
- UCB Stock
- 0NZT Stock
- Sector UCB
Select your edition
All financial news and data tailored to specific country editions
